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Public health policy in the UK related to nutrition and bone health has been shaped by reports from the Department of Health (DH), Food
Standards Agency and WHO. Dietary reference values (DRV) for a number of nutrients were published in 1991 by the DH Committee on Medi-
cal Aspects of Food and Nutrition Policy. The subsequent DH report on nutrition and bone health in 1998 concentrated particularly on Ca and
vitamin D, but also briefly addressed the effect of body weight, alcohol and other nutrients. Although this reviewed more recent evidence relat-
ing to the effect of higher intakes of Ca and vitamin D from longitudinal and interventional studies, no changes were made to the existing DRV.
The Food Standards Agency published a report from their Expert Group on Vitamins and Minerals in 2003, which recommended safe upper
limits for eight vitamins and minerals, with guidance provided on a further twenty-two nutrients, where there was less information on
safety. The WHO report on diet, nutrition and the prevention of chronic diseases in 2003 addressed the prevention of osteoporosis, making
recommendations on Ca, vitamin D, Na, fruit and vegetables, alcohol and body weight. The present paper examines current views on what
constitutes an adequate dietary Ca intake and optimal vitamin D status, the DRV for vitamin D in subjects with little or no exposure to sunlight
and the results of recent epidemiological studies on the relationship between fracture risk and body weight, alcohol intake and the consumption
of other nutrients.
Bone health: Public health policy: Calcium: Vitamin D
Bone diseases such as osteoporosis and osteomalacia are a
major cause of excess mortality, morbidity and health and
social services expenditure in older individuals, because of
their association with low trauma fractures and skeletal
deformity. The importance of Ca and vitamin D in the main-
tenance of bone health has stimulated interest in the potential
role of other nutritional factors.
A number of reports and documents have shaped and influ-
enced public health policy on nutrition and bone health in the
UK. The UK Department of Health Committee on Medical
Aspects of Food and Nutrition Policy (COMA) report on diet-
ary reference values (DRV) in 1991 included nutrients rel-
evant to bone health1. The Department of Health Advisory
Group on Osteoporosis report in 1994 suggested that DRV
should be reviewed, in the light of more recent studies2.
This was undertaken in the Department of Health report on
nutrition and bone health in 1998, which particularly concen-
trated on Ca and vitamin D3. Other nutritional factors were
addressed briefly, including body weight, protein, vitamins
K and C, Mg, P, Na, K, fluorine, alcohol, caffeine and
phyto-oestrogens3.
The Food Standards Agency Expert Group on Vitamins and
Minerals published a report on safe upper limits of nutrients in
2003, which included a detailed review of nutritional and toxi-
cological data on thirty-four vitamins and minerals4. Safe
upper limits were recommended for eight of the nutrients,
whilst guidance was provided for twenty-two vitamins and
minerals where the evidence was less clear, including those
related to bone health. Ca supplementation up to 1500mg/d
was regarded as safe, as was vitamin D up to 25mg
(1000 IU) daily and vitamin A up to 1500mg retinol equiva-
lents daily4.
The WHO published a report on diet, nutrition and the pre-
vention of chronic diseases in 20035. The osteoporosis section
suggested that in countries with a high fracture incidence, low
Ca intake (,400–500mg/d) was associated with increased
risk in older individuals. It was suggested that an increase in
dietary intake of vitamin D and Ca in this group could
reduce fracture risk. If sunshine exposure was limited, a vita-
min D intake of 5–10mg (200–400 IU) daily was also rec-
ommended. This report also summarised the evidence that
other nutritional factors either increased or decreased the
risk of fracture5. Although many studies have examined the
effect of nutrition on markers of bone health, such as bio-
chemical markers of bone turnover and bone mineral density
(BMD), fracture is the most important outcome measure.
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Dietary requirements for calcium
DRV for Ca were set by the Committee on Medical Aspects
of Food and Nutrition Policy in 1991, based on factorial
calculations which take into account the efficiency of Ca
absorption, obligatory losses in the faeces, urine and sweat
and the requirements for growth in childhood1. The reference
nutrient intake (RNI) of 700mg/d for adults, which should
provide sufficient Ca for 97·5% of the adult population,
is two standard deviations above the estimated average
requirement of 550mg/d. The lower RNI is 400mg/d,
below which dietary Ca is likely to be inadequate, is two
standard deviations lower than the estimated average require-
ment. No other measure of bone health was considered in
1991, but the subsequent report in 1998 examined the effects
of high Ca intakes on BMD and fracture incidence in longi-
tudinal and intervention studies3. This report endorsed the
earlier DRV (Table 1), but it was felt that the additional
550mg/d in lactation was probably unnecessary.
Dietary calcium intake in the United Kingdom
The major source of Ca is dairy produce, but other Ca-rich
foods include flour, cereals, fish such as sardines and veg-
etables such as spinach and broccoli. The National Diet and
Nutrition Survey showed that 79% of boys and girls aged
11–14 years have a dietary Ca intake lower than the RNI,
with 12% of boys and 24% of girls in this age group
having an intake below the lower RNI6. In contrast, only
2% of men and 5% of women aged 19–64 years have a diet-
ary intake below the lower RNI7. In older women, the pro-
portion with a Ca intake below the lower RNI increases
from 8% between the ages of 65 and 74 years to 15% at 85
years and older, whereas the corresponding figures for men
are 4% and 2% respectively8.
Calcium supplementation
In view of the potentially inadequate dietary Ca intake in chil-
dren and older individuals, it is important to review the effects
of supplementation on bone health. A recently published
meta-analysis of fifteen randomised controlled trials involving
2859 children examined the effects of the addition of 300–
1200mg elemental Ca in supplementation or dairy produce9.
The duration of Ca supplementation ranged from 8 months
to 4 years and post-supplementation follow up from 8
months to 8 years. This meta-analysis concluded that there
was no significant effect of Ca supplementation on femoral
neck or lumbar spine BMD. There was a small effect on
total body bone mineral content and upper-limb BMD, but it
is felt that this was unlikely to influence the risk of subsequent
fractures. There is some debate about the appropriateness of
using BMD as a single marker of bone health in children
and adolescents, where considerations about skeletal mass
and size are also required10.
A meta-analysis of Ca supplementation examined fifteen
randomised controlled trials in 1806 postmenopausal
women with BMD or fractures as outcome measures11. Ca
decreased bone loss by 1·66 (95% CI 0·92, 2·39) % at the
spine, 1·64 (95% CI 0·70, 2·57) % at the hip and 2·05
(95% CI 0·24, 3·86) % for total body BMD. Despite this
beneficial effect on bone loss, there was no reduction in
the risk of vertebral fractures (relative risk 0·77 (95% CI
0·54, 1·09)) or non-vertebral fractures (relative risk 0·86
(95% CI 0·43, 1·72)).
The Women’s Health Initiative Study of Ca and vitamin D
supplementation was performed in 36 282 post-menopausal
women aged 50–79 years12. These were randomised to
receive Ca (1000mg) and vitamin D (10mg; 400 IU) or
placebo daily. Although Ca and vitamin D supplementation
resulted in a small beneficial effect on bone loss, there was
no overall reduction in fractures, clinical vertebral fractures
or hip fractures. Post hoc analysis suggested that Ca and vita-
min D supplementation decreased the risk of fractures in
older individuals and in those who remained compliant
with treatment. Nevertheless, any potential benefits were
offset by an increased risk of renal stones (hazard ratio
1·17 (95% CI 1·02, 1·34)). Other studies show that although
Ca supplementation increases the risk of renal stones, a high
dietary intake of Ca is associated with a lower risk of renal
stones13.
The results of these studies suggest that the DRV for Ca in
the UK are appropriate and do not support the routine use of
Ca supplementation in the general population. Nevertheless, a
significant proportion of younger adolescents and older indi-
viduals have a dietary Ca intake lower than the DRV and
may benefit from an increased Ca intake.
Dietary requirements for vitamin D
The major source of vitamin D is cutaneous production, fol-
lowing exposure to UV radiation. The diet generally provides
smaller amounts of vitamin D, but this source is essential
when cutaneous production is limited, because of lack of
exposure to sunlight. The major dietary sources of vitamin
D are fortified margarine and other fat spreads, cereals, oily
fish, meat eggs and dairy produce. The most important conse-
quence of vitamin D deficiency is the development of osteo-
malacia, which is characterised by an impairment of bone
mineralisation and accumulation of osteoid. The DRV for vita-
min D set in 1991 were based on the dietary amount required
to ensure that the serum 25-hydroxyvitamin D (25OHD)
in winter was above 20 nmol/l, as vitamin D-deficiency
osteomalacia generally only occurs in individuals with lower
circulating concentrations1. When the DRV for vitamin D
Table 1. Dietary reference values for calcium in the UK1,3
RNI (mg) LRNI (mg)
Childhood
0–12 months 525 240
1–3 years 350 200
4–6 years 450 275
7–10 years 550 325
11–18 years (male) 1000 480
11–18 years (female) 800 450
Adulthood
19 þ years 700 400
Lactation þ550*
RNI, reference nutrient intake; LRNI, lower reference nutrient intake.
* The additional requirement may not be required during lactation3.
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were reviewed by the Department of Health Nutrition and
Bone Health report in 1998, no changes to the RNI were
made3. No RNI was set for children above the age of 3
years or adults below the age of 65 years, unless they were
considered at risk of vitamin D deficiency (because of strict
dress code, being house-bound or having increased skin pig-
mentation) when an RNI of 10mg (400 IU) daily was set. It
is important to consider if this RNI is adequate in individuals
with no cutaneous production of vitamin D, such as comple-
tely veiled women or submariners. In the latter group, vitamin
D intakes of 15mg (600 IU) daily are required to maintain
serum 25OHD at its previous level14. As the mean intake of
vitamin D from food sources in adults in the UK ranges
2·0–4·0mg (80–160 IU) daily7,8, most individuals at risk of
developing vitamin D deficiency will require supplementation.
This should probably be administered as vitamin D3 (cholecal-
ciferol) rather than vitamin D2 (ergocalciferol), as there is evi-
dence suggesting that the metabolism of the latter may be
impaired15. In a study of twenty normal healthy men, a
single oral dose of 1·25mg (50 000 IU) of either vitamin D2
or vitamin D3 was administered, following which the change
in serum 25OHD was monitored over a 28 d period. Although
there were similar increases in serum 25OHD in the first 3 d
after the administration of vitamin D2 and vitamin D3, at the
end of the study the serum 25OHD was 50 nmol/l above base-
line after vitamin D3 administration, but was 5 nmol/l lower
than the initial value in the vitamin D2-treated group
15.
Vitamin D deficiency in the United Kingdom
The prevalence of vitamin D deficiency in older individuals in
the UK was examined in the National Diet and Nutrition
Survey8. Using a threshold value of serum 25OHD of
,25 nmol/l, the prevalence of vitamin D deficiency increased
from 5–6% between the ages of 65 and 74 years to 13–25%
above the age of 85 years. The prevalence of vitamin D
deficiency in care-home residents was higher than 36%.
Similar findings were reported in the recent Health Survey
for England16.
Although classically vitamin D deficiency has been associ-
ated with osteomalacia, there has been growing interest in the
role of vitamin D insufficiency and secondary hyperparathy-
roidism in the development of osteoporosis and low trauma
fractures17. There is an inverse relationship between serum
25OHD and parathyroid hormone, but no clear evidence of
a threshold value of 25OHD above which parathyroid hor-
mone reaches a plateau18. The relationship between 25OHD
and parathyroid hormone may be used to establish a threshold
value for vitamin D insufficiency, but there is no clear agree-
ment on the appropriate level to select19. This may have been
aggravated by the use of different assays for serum 25OHD20.
Lips has classified vitamin D insufficiency as mild (serum
25OHD 25–50 nmol/l), moderate (serum 25OHD 12·5–
25 nmol/l) and severe (serum 25OHD , 12·5 nmol/l)17.
North American experts have suggested that higher levels
of 25OHD are essential not only to maintain bone health19,
but also for mental health, prevention of cancers, cardiovas-
cular health, and for the prevention of skin and autoimmune
disorders21. Holick & Jenkins suggest that a healthy 25OHD
is between 75–150 nmol/l, whilst the minimum for cell
health is 75 nmol/l and the minimum for bone health is
50 nmol/l21. Relatively few individuals in the UK achieve
these levels of 25OHD in winter and spring, when over
80% of 45-year-old men and women have a serum concen-
tration , 75 nmol/l22.
Heaney et al. examined the effects of different doses of
vitamin D supplementation in sixty-seven men living in
Omaha (NE, USA)23. These men were treated with oral vita-
min D3 at 0, 25, 125 or 250mg daily for 20 weeks during the
winter. Serum 25OHD measurements were performed regu-
larly during this time. The maximum serum 25OHD achieved
with 25mg daily was approximately 75 nmol/l, whilst the
values for 125mg daily were 140 nmol/l and that for 250mg
was 200 nmol/l. A recent paper reviewed the optimal serum
25OHD concentration suggested by experts and the doses of
oral vitamin D3 required to achieve these levels
19. Heaney
et al. suggested that a 25OHD of 80 nmol/l was appropriate,
which required an oral vitamin D intake of 40mg (1600 IU)
daily19. Although this is higher than the daily upper intake
of 25mg (1000 IU) vitamin D recommended by the Food Stan-
dards Agency Expert Group on Vitamins and Minerals4, a
recent review suggests that intakes as high as 250mg
(10 000 IU) daily are safe24, at least in the short term.
Vitamin D supplementation
A meta-analysis of vitamin D supplementation published in
2005 indicated that doses of 17·5·20mg (700–800 IU) daily
decreased the risk of hip and other non-vertebral fractures,
whereas lower doses (10mg; 400 IU daily) were ineffective25.
A number of recent studies cast doubt on the role of vitamin D
supplementation, with or without Ca, in the prevention of frac-
tures in older individuals12,26–30. A recent Cochrane review31,
which includes some of these recent studies26–28, suggests that
vitamin D used alone has no significant effect on hip fracture
(seven trials; 18 668 participants; relative risk 1·17 (95% CI
0·98, 1·41)). In contrast, combined supplementation with vita-
min D and Ca marginally reduced the risk of hip fractures
(seven trials; 10 376 participants; relative risk 0·81 (95% CI
0·68, 0·96)), but the effect appeared to be restricted to those
living in institutional care31. Another recent meta-analysis
also shows a similar reduction in hip fractures with Ca and
vitamin D (relative risk 0·82 (95% CI 0·71, 0·94)), with no
beneficial effect of vitamin D alone on fracture incidence32.
Two recent studies have examined the effects of vitamin D
in care-home residents, who are likely to be vitamin D
deficient29,30. Law performed a cluster randomised trial of
oral vitamin D2 (2·5mg; 100 000 IU) three-monthly in 3717
care-home residents29. Serum 25OHD in a small sub-set
increased from 47 to 82 nmol/l after 1month and 74 nmol/l
after 3 months. Despite this improvement in vitamin D
status, there was no reduction in falls (relative risk 1·09
(95% CI 0·95, 1·25)) or fractures (relative risk 1·48 (95%
CI 0·99, 2·20)). A second randomised controlled trial by
Lyons et al. examined the effect of oral vitamin D2 (2·5mg;
100 000 IU) four-monthly in 3440 care-home residents30.
Baseline serum 25OHD measurements were not performed,
but during the study these were 80 and 54 nmol/l respectively
in a small sub-set of the intervention and control group. There
was no reduction in fracture risk with vitamin D supplemen-
tation (hazard ratio 0·95 (95% CI 0·8, 1·20)).
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Although there is controversy about what constitutes ade-
quate vitamin D status, the recent studies of vitamin D sup-
plementation suggest that the conservative thresholds
adopted in the UK may be more appropriate than those advo-
cated in North America. Combined Ca and vitamin D sup-
plementation may decrease fracture risk in care-home
residents, in whom vitamin D deficiency is common, but is
probably ineffective in the prevention of fractures in commu-
nity-dwelling older individuals. Future studies of vitamin D
supplementation should include measurements of vitamin D
status in a greater proportion of the participants than in pre-
vious trials, to investigate the relationship between putative
benefits and the baseline and peak serum 25OHD concen-
trations achieved with supplementation.
Other nutritional factors
The effect of low BMI was examined in a recent meta-analysis
in 14 887 men and 44 757 women from twelve prospective
cohort studies33. This showed little effect of BMI on fracture
risk between 25 and 35 kg/m2, but the risk of hip fracture
increased dramatically as the BMI fell below 25 kg/m2. The
relative risk of hip fracture at a BMI of 20 kg/m2was 1·95
increasing to 4·48 at a BMI of 15 kg/m2.
The effect of alcohol consumptionwas also examined in 5939
men and 11 032 women from three prospective cohort studies34.
This suggested that the risk of fractures increased in men drink-
ing ^ 3 units alcohol/d. Although the overall risk of osteoporo-
tic fractures in women only increased with an intake of
^ 4 units/d, hip fractures increased with only 3 units/d.
There has been growing interest in the role of fruit and veg-
etables in the maintenance of bone health. Studies show a ben-
eficial effect on bone density and bone turnover markers, but
there is no evidence yet of a reduction in fracture risk35. It is
also currently unclear if the putative benefits of fruit and veg-
etable consumption are mediated in changes in acid–base bal-
ance, vitamin K or the consumption of antioxidants.
Although our knowledge of the effects of nutrition on bone
health is gradually increasing, there are still a large number of
unanswered questions. It is therefore important to remember
Voltaire, who stated that ‘only charlatans are certain. . . doubt
is not a very agreeable state, but certainty is a ridiculous one.’
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